MedStar Authors catalog › Details for: COVID-19 (SARS-Cov-2) and the heart - An ominous association.
Normal view MARC view ISBD view

COVID-19 (SARS-Cov-2) and the heart - An ominous association.

by Ben-Dor, Itsik; Case, Brian C; Chen, Yuefeng; Khalid, Nauman; Rogers, Toby; Shlofmitz, Evan; Waksman, Ron; Wermers, Jason P.
Citation: Cardiovascular Revascularization Medicine. 21(8):946-949, 2020 08.; .Journal: Cardiovascular revascularization medicine : including molecular interventions.Published: 2020; ; ; ISSN: 1878-0938.Full author list: Ben-Dor I; Case BC; Chen Y; Khalid N; Rogers T; Shlofmitz E; Waksman R; Wermers JP.UI/PMID: 32423791.Subject(s): *Betacoronavirus | *Coronavirus Infections/co [Complications] | *Glucocorticoids/tu [Therapeutic Use] | *Myocarditis/et [Etiology] | *Pandemics | *Pneumonia, Viral/co [Complications] | *ST Elevation Myocardial Infarction/et [Etiology] | *Thrombolytic Therapy/mt [Methods] | Adult | Coronary Angiography | Coronavirus Infections/ep [Epidemiology] | Echocardiography | Electrocardiography | Female | Humans | Male | Middle Aged | Myocarditis/di [Diagnosis] | Myocarditis/dt [Drug Therapy] | Pneumonia, Viral/ep [Epidemiology] | ST Elevation Myocardial Infarction/di [Diagnosis] | ST Elevation Myocardial Infarction/dt [Drug Therapy]Institution(s): MedStar Heart & Vascular InstituteActivity type: Journal Article.Medline article type(s): Case ReportsOnline resources: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1016/j.carrev.2020.05.009https://dx.doi.org/10.1016/j.carrev.2020.05.009 (Click here) | (Click here) Abbreviated citation: Cardiovasc Revasc Med. 21(8):946-949, 2020 08; .Local Holdings: Available in print through MWHC library: 2002 - present.Abstract: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Cardiovascular manifestations of COVID-19 are diverse and complex and include acute coronary syndrome, myocarditis masquerading as ST-segment elevation myocardial infarction, pericarditis and pericardial effusion. We present 2 cases of COVID-19 infection with myocardial involvement with distinct mechanistic pathways and outcomes. Important decision strategies such as the timing of cardiac catheterization (when indicated) and requirement of early hemodynamic support in critically ill patients are discussed. Copyright (c) 2020 Elsevier Inc. All rights reserved.

Powered by Koha